His main research concerns Mesoporous silica, Nanoparticle, Nanotechnology, Drug delivery and Photon upconversion. His study in Mesoporous silica is interdisciplinary in nature, drawing from both Biophysics, Chromatography, Drug and PEGylation. The study incorporates disciplines such as Mesoporous organosilica, Pulmonary surfactant, Biodistribution and Particle size in addition to Nanoparticle.
His Nanotechnology research is multidisciplinary, relying on both Mri guided, Photodynamic therapy, Hematoporphyrin, Mesoporous material and Biomedical engineering. His biological study spans a wide range of topics, including Cancer cell and Drug resistance. In his study, Nanomedicine is inextricably linked to Metastasis, which falls within the broad field of Drug resistance.
Nanotechnology, Mesoporous silica, Nanoparticle, Drug delivery and Nanomedicine are his primary areas of study. His Nanotechnology study combines topics in areas such as Luminescence and Nano-. His work in Mesoporous silica covers topics such as Hydrogen which are related to areas like Biophysics and Solubility.
His studies in Nanoparticle integrate themes in fields like Biocompatibility, Micelle, Fluorescence, Particle size and Combinatorial chemistry. His Drug delivery study integrates concerns from other disciplines, such as Cancer cell and Controlled release, Pharmacology, Drug. Qianjun He interconnects Cancer therapy, Oxide, Risk analysis and Graphene in the investigation of issues within Nanomedicine.
His primary areas of investigation include Controlled release, Nanotechnology, Nanomedicine, Drug delivery and Hydrogen. His study looks at the intersection of Controlled release and topics like Prodrug with Doxorubicin and Tretinoin. Nanotechnology is closely attributed to Nano- in his study.
The concepts of his Nanomedicine study are interwoven with issues in Cancer therapy, Cancer research and Combination therapy. Qianjun He regularly ties together related areas like Combinatorial chemistry in his Drug delivery studies. His studies link Mesoporous silica with Hydrogen.
The scientist’s investigation covers issues in Hydrogen, Controlled release, Nanomedicine, Drug delivery and Biophysics. His research in Hydrogen intersects with topics in Nanotechnology and Photothermal therapy. Qianjun He has included themes like Hydrogen storage and Particle size in his Nanotechnology study.
His Controlled release study combines topics from a wide range of disciplines, such as Metal carbonyl, Prodrug, Fluorescence-lifetime imaging microscopy and Doxorubicin. His research on Nanomedicine also deals with topics like
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Nuclear-targeted drug delivery of TAT peptide-conjugated monodisperse mesoporous silica nanoparticles.
Limin Pan;Qianjun He;Jianan Liu;Yu Chen.
Journal of the American Chemical Society (2012)
Mesoporous silica nanoparticle based nano drug delivery systems: synthesis, controlled drug release and delivery, pharmacokinetics and biocompatibility
Qianjun He;Jianlin Shi.
Journal of Materials Chemistry (2011)
Hollow/rattle-type mesoporous nanostructures by a structural difference-based selective etching strategy.
Yu Chen;Hangrong Chen;Limin Guo;Qianjun He.
ACS Nano (2010)
In vivo Biodistribution and Urinary Excretion of Mesoporous Silica Nanoparticles: Effects of Particle Size and PEGylation
Qianjun He;Zhiwen Zhang;Fang Gao;Yaping Li.
Intelligent MnO2 Nanosheets Anchored with Upconversion Nanoprobes for Concurrent pH‐/H2O2‐Responsive UCL Imaging and Oxygen‐Elevated Synergetic Therapy
Wenpei Fan;Wenbo Bu;Wenbo Bu;Bo Shen;Qianjun He.
Advanced Materials (2015)
The effect of PEGylation of mesoporous silica nanoparticles on nonspecific binding of serum proteins and cellular responses
Qianjun He;Jiamin Zhang;Jianlin Shi;Ziyan Zhu.
Multifunctional nanoprobes for upconversion fluorescence, MR and CT trimodal imaging
Huaiyong Xing;Wenbo Bu;Shengjian Zhang;Xiangpeng Zheng.
A pH-responsive mesoporous silica nanoparticles-based multi-drug delivery system for overcoming multi-drug resistance.
Qianjun He;Yu Gao;Lingxia Zhang;Zhiwen Zhang.
MSN anti-cancer nanomedicines: chemotherapy enhancement, overcoming of drug resistance, and metastasis inhibition.
Qianjun He;Qianjun He;Jianlin Shi.
Advanced Materials (2014)
Intracellular localization and cytotoxicity of spherical mesoporous silica nano- and microparticles.
Qianjun He;Zhiwen Zhang;Yu Gao;Jianlin Shi.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: